Tissue-specific Transcription Reprogramming Promotes Liver Metastasis of Colorectal Cancer.

Shuaishuai Teng,Yang Eric Li,Ming Yang,Rui Qi,Yiming Huang,Qianyu Wang,Yanmei Zhang,Shanwen Chen,Shasha Li,Kequan Lin,Yang Cao,Qunsheng Ji,Qingyang Gu,Yujing Cheng,Zai Chang,Wei Guo,Pengyuan Wang,Ivan Garcia-Bassets,Zhi John Lu,Dong Wang
DOI: https://doi.org/10.1038/s41422-019-0259-z
IF: 44.1
2020-01-01
Cell Research
Abstract:Metastasis, the development of secondary malignant growths at a distance from a primary tumor, is the cause of death for 90% of cancer patients, but little is known about how metastatic cancer cells adapt to and colonize new tissue environments. Here, using clinical samples, patient-derived xenograft (PDX) samples, PDX cells, and primary/metastatic cell lines, we discovered that liver metastatic colorectal cancer (CRC) cells lose their colon-specific gene transcription program yet gain a liver-specific gene transcription program. We showed that this transcription reprogramming is driven by a reshaped epigenetic landscape of both typical enhancers and super-enhancers. Further, we identified that the liver-specific transcription factors FOXA2 and HNF1A can bind to the gained enhancers and activate the liver-specific gene transcription, thereby driving CRC liver metastasis. Importantly, similar transcription reprogramming can be observed in multiple cancer types. Our data suggest that reprogrammed tissue-specific transcription promotes metastasis and should be targeted therapeutically.
What problem does this paper attempt to address?